Press Releases

Year

June 6, 2019

Establishment Labs Announces Appointment of Lisa Gersh to Board of Directors

NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Lisa Gersh to its Board of Directors, effective

May 22, 2019

Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve

NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has reached an agreement with Allergan Sales, LLC to extend an

May 20, 2019

Establishment Labs to Present at Jefferies 2019 Healthcare Conference

NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Chief Executive Officer Juan José Chacón-Quirós will be presenting

May 15, 2019

Establishment Labs Reports First Quarter 2019 Financial Results

NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2019.

April 26, 2019

Establishment Labs to Present at UBS Global Healthcare Conference

NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will be presenting at the

April 24, 2019

Establishment Labs to Announce First Quarter 2019 Financial Results

NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the first quarter

March 20, 2019

Establishment Labs Reports Fourth Quarter and Full Year 2018 Financial Results

NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended

March 1, 2019

Establishment Labs to Present at the Cowen 39th Annual Health Care Conference

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José

February 25, 2019

Establishment Labs to Announce Fourth Quarter and Full Year 2018 Financial Results

NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial

Investors

Press Releases

Press Releases